CLINICAL AND MOLECULAR DATA ON MENTAL RETARDATION IN BULGARIA
Todorov T1#, Todorova A1#, Avdjieva D2, Dimova P3, Angelova L4, Tincheva R2 and Mitev V1
*Corresponding Author: Tihomir Todorov, Department of Medical Chemistry and Biochemistry, Sofia Medical University, 2 “Zdrave” str., Sofia 1431, Bulgaria; Tel./Fax: +359 29530715; tisho.todorov@abv.bg
page: 11
download article in pdf format

Abstract

Mental retardation (MR) is clinically and genetically highly heterogeneous. We have done molecular genetic testing on 85 Bulgarian MR patients who were clinically classed as fragile X syndrome (FXS) (n = 32), Rett syndrome (RTT) (n = 36) and Prader-Willi/Angelman syndromes (PWS/AS) (n = 17). We tested for the fragile X MR 1 (FMR1), methyl-CpG binding protein 2 (MECP2), cyclin dependent kinase-like 5 (CDKL5), and Aristaless X (ARX) genes, and did methylation analyses of exon 1 of the small nuclear ribonucleoprotein polypeptide N (SNRPN), and multiplex ligation-dependent probe amplification (MLPA) analyses for large deletions/ duplications, and for the methylation status of FMR1 and SNRPN genes. In the FXS group we only found four mutations in the FMR1 gene (12.5%). In the RTT group we found nine mutations in the MECP2 gene (25.0%) but no CDKL5 gene mutations. In the PWS/ AS group we found nine mutations in the 15q11-q13 region (53%). Thus, we clarified the molecular basis in 26.0% of the patients. The proportion of genetically proved diagnoses in our RTT patients (25.0%) is relatively high and all these cases are due to MECP2 mutations. Despite the type of mutation, all these cases are very similar from the clinical point of view and well recognized in Bulgaria.



Number 19
VOL. 19 (2), 2016
Number 19
VOL. 19 (1), 2016
Number 18
VOL. 18 (2), 2015
Number 18
VOL. 18 (1), 2015
Number 17
VOL. 17 (2), 2014
Number 17
VOL. 17 (1), 2014
Number 16
VOL. 16 (2), 2013
Number 16
VOL. 16 (1), 2013
Number 15
VOL. 15 (2), 2012
Number 15
VOL. 15, 2012 Supplement
Number 15
Vol. 15 (1), 2012
Number 14
14 - Vol. 14 (2), 2011
Number 14
The 9th Balkan Congress of Medical Genetics
Number 14
14 - Vol. 14 (1), 2011
Number 13
Vol. 13 (2), 2010
Number 13
Vol.13 (1), 2010
Number 12
Vol.12 (2), 2009
Number 12
Vol.12 (1), 2009
Number 11
Vol.11 (2),2008
Number 11
Vol.11 (1),2008
Number 10
Vol.10 (2), 2007
Number 10
10 (1),2007
Number 9
1&2, 2006
Number 9
3&4, 2006
Number 8
1&2, 2005
Number 8
3&4, 2004
Number 7
1&2, 2004
Number 6
3&4, 2003
Number 6
1&2, 2003
Number 5
3&4, 2002
Number 5
1&2, 2002
Number 4
Vol.3 (4), 2000
Number 4
Vol.2 (4), 1999
Number 4
Vol.1 (4), 1998
Number 4
3&4, 2001
Number 4
1&2, 2001
Number 3
Vol.3 (3), 2000
Number 3
Vol.2 (3), 1999
Number 3
Vol.1 (3), 1998
Number 2
Vol.3(2), 2000
Number 2
Vol.1 (2), 1998
Number 2
Vol.2 (2), 1999
Number 1
Vol.3 (1), 2000
Number 1
Vol.2 (1), 1999
Number 1
Vol.1 (1), 1998

 

 


 About the journal ::: Editorial ::: Subscription ::: Information for authors ::: Contact
 Copyright © Balkan Journal of Medical Genetics 2006